Access Statistics for Dana P. Goldman

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Economic Evaluation of the War on Cancer 0 0 0 97 3 3 4 364
Are the Young Becoming More Disabled? 0 0 0 93 3 6 6 352
Can Patient Self-Management Help Explain the SES Health Gradient? 0 0 0 161 2 5 8 624
Criminal Prosecution and HIV-related Risky Behavior 0 0 0 27 2 4 6 257
Disentangling Moral Hazard and Adverse Selection in Private Health Insurance 0 0 1 52 1 4 9 131
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 3 5 6 41
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 0 1 5 41
Employee Responses to Health Insurance Premium Increases 0 0 0 23 0 1 1 176
Food Prices and the Dynamics of Body Weight 0 0 0 71 0 1 1 233
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 1 1 2 636
Health Care Spending: Historical Trends and New Directions 0 0 0 41 2 4 6 84
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 1 2 3 194
Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician 0 0 0 3 1 2 4 49
Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand 0 0 0 127 2 6 9 460
How Costly Is Hospital Quality? A Revealed-Preference Approach 0 0 0 91 2 3 4 306
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 3 1 1 6 43
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 95 3 4 8 167
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 0 1 2 6 12
Integrated Insurance Design in the Presence of Multiple Medical Technologies 0 0 0 23 1 2 4 173
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 0 3 4 126
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 0 1 2 265
International Differences in Longevity and Health and their Economic Consequences 0 0 0 55 2 6 9 177
Market Evidence of Misperceived Prices and Mistaken Mortality Risks 0 0 0 51 1 1 3 295
Medical Expenditure Risk and Household Portfolio Choice 0 0 0 76 3 4 7 339
Medical Expenditure Risk and Household Portfolio Choice 0 0 0 4 1 2 2 87
Moral Hazard and Adverse Selection in Private Health Insurance 0 1 1 20 4 7 12 77
Prescription Drug Coverage and Elderly Medicare Spending 0 0 0 49 4 4 4 349
Price Variation in Markets with Homogeneous Goods The Case of Medigap 0 0 0 1 0 0 0 20
Price Variation in Markets with Homogeneous Goods: The Case of Medigap 0 0 0 43 1 4 5 269
Productivity Growth in Treating a Major Chronic Health Condition 0 0 0 0 3 4 4 8
Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 0 2 4 4 5
Socioeconomic Differences in the Adoption of New Medical Technologies 0 0 0 65 0 0 2 269
Terminal Care and The Value of Life Near Its End 0 1 2 211 1 3 10 701
The Effects of Product Liability Exemption in the Presence of the FDA 0 0 0 19 1 1 4 198
The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006 0 0 0 81 1 3 5 226
The Effects of Relative Food Prices on Obesity – Evidence from China: 1991-2006 0 0 0 31 1 6 9 153
The Future of the Elderly Population Health Status: Filling a Knowledge Gap 0 0 0 34 3 5 7 64
The Link Between Public and Private Insurance and HIV-Related Mortality 0 0 0 79 0 0 4 487
The Reallocation of Compensation in Response to Health Insurance Premium Increases 0 0 0 52 4 5 7 345
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 0 29 2 4 5 169
Understanding Health Disparities Across Education Groups 0 0 2 398 5 6 15 1,710
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 43 0 3 6 229
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 2 4 7 184
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 0 0 111
Wage and Benefit Changes in Response to Rising Health Insurance Costs 0 0 0 54 2 5 5 299
Total Working Papers 0 2 6 2,718 72 142 240 11,505

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Reexamination of the Costs of Medical R&D Regulation 0 0 0 13 1 2 3 70
A Theory of Health Disparities and Medical Technology 0 0 3 146 2 6 19 624
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 15 1 1 3 104
An economic evaluation of the war on cancer 0 0 1 108 1 3 8 585
Are Biopharmaceutical Budget Caps Good Public Policy? 0 1 1 13 1 3 3 75
Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis 0 0 0 0 0 2 2 2
Can patient self-management explain the health gradient? revisited: A response to Maitra 0 0 0 12 0 1 1 40
Can the ACA Improve Population Health? 0 0 0 14 1 5 5 73
Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior 0 0 0 8 1 3 4 100
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 27 2 2 3 110
Digesting the doughnut hole 0 1 1 7 3 5 6 59
Disability Forecasts and Future Medicare Costs 0 1 1 35 2 4 6 278
Disentangling moral hazard and adverse selection in private health insurance 2 2 3 16 6 12 29 88
Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context 0 0 0 1 1 3 4 11
Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? 0 0 0 4 3 5 7 66
Do Statins Reduce the Health and Health Care Costs of Obesity? 0 0 0 7 1 1 4 34
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 0 0 2 18
Does age or life expectancy better predict health care expenditures? 0 1 1 88 1 2 5 305
Effect of COVID-19 vaccine allocation strategies on vaccination refusal: a national survey 0 0 0 1 0 2 5 8
Effect of Insurance on Mortality in an HIV-Positive Population in Care 0 0 0 15 1 2 4 89
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 1 3 3 23
Estimated prevalence of undiagnosed atrial fibrillation in the United States 0 0 0 0 2 3 4 11
Geographic Variation in Health Care: The Role of Private Markets 0 0 0 75 0 2 6 423
Geographic variation in the delivery of high-value inpatient care 0 0 0 0 1 4 8 15
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 2 2 3 27
HIV Breakthroughs and Risky Sexual Behavior 0 0 0 166 3 5 14 925
Health Care Spending: Historical Trends and New Directions 0 0 0 7 2 5 8 86
Health and Health Care of Medicare Beneficiaries in 2030 0 0 0 8 3 4 7 59
How Costly is Hospital Quality? A Revealed‐Preference Approach 0 0 0 7 0 0 1 64
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 0 41 0 6 13 262
IT IS TIME FOR UNIVERSAL COVERAGE WITHOUT BREAKING THE BANK 1 1 1 8 2 3 3 24
Improved survival for individuals with common chronic conditions in the Medicare population 0 0 0 0 1 1 3 6
Integrated Insurance Design in the Presence of Multiple Medical Technologies 0 0 0 23 1 2 2 247
MEDICAL EXPENDITURE RISK AND HOUSEHOLD PORTFOLIO CHOICE 0 0 0 0 1 3 6 192
MEDICARE†FOR†ALL: NOT OUR ONLY OPTION FOR UNIVERSAL COVERAGE 0 0 0 1 1 2 4 15
Managed Care as a Public Cost-Containment Mechanism 0 0 0 48 2 2 4 521
Market evidence of misperceived mortality risk 0 0 0 10 1 1 3 35
Medical Expenditure Measures in the Health and Retirement Study 0 0 0 34 1 1 3 122
Part D Formulary and Benefit Design as a Risk-Steering Mechanism 0 0 0 26 1 1 1 134
Patient Cost-Sharing and Healthcare Spending Growth 0 0 0 65 0 4 8 278
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 1 2 51 2 4 11 191
Political polarization in US residents’ COVID-19 risk perceptions, policy preferences, and protective behaviors 0 0 0 3 2 3 7 45
Predicting quantity and quality of life with the Future Elderly Model 0 0 0 2 1 2 4 15
Prescription Drug Coverage and Medicare Spending among U.S. Elderly 0 0 0 0 0 1 1 1
Prescription Drug Coverage and Medicare Spending among U.S. Elderly&ast 0 0 0 16 1 1 1 82
Price Regulation in Secondary Insurance Markets 0 0 1 14 3 5 7 89
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 0 41 1 3 6 159
Queuing for Surgery: Is the U.S. or Canada Worse Off? 0 0 2 148 4 4 9 1,131
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 0 0 18
Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards 0 0 0 3 2 3 3 54
Racial and ethnic disparities in medication adherence among privately insured patients in the United States 0 0 0 2 1 3 5 13
Socioeconomic Differences in the Adoption of New Medical Technologies 0 0 0 34 2 5 8 237
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 0 72 2 3 4 299
The Costs of A Medicare Prescription Drug Benefit 0 0 0 61 1 1 5 665
The Fiscal Consequences of Trends in Population Health 0 0 0 15 1 3 5 70
The Future of US Health Care: Is Medicare Really Better at “Saving” Money? 0 0 0 29 0 1 2 96
The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare 0 0 0 42 2 2 2 181
The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older 0 0 0 0 0 1 1 3
The Returns to Preventing Chronic Disease in Europe and the United States 0 0 5 29 1 3 10 48
The Value of Diagnostic Testing in Personalized Medicine 0 0 0 60 1 1 7 225
The Value of Elderly Disease Prevention 0 0 0 116 1 1 2 441
The association between observed mobility and quality of life in the near elderly 0 0 0 0 3 4 5 8
The benefits of risk factor prevention in Americans aged 51 years and older 0 0 0 1 1 2 3 13
The economics of alternative payment models for pharmaceuticals 0 0 0 9 1 3 5 42
The effects of benefit design and managed care on health care costs 0 0 0 28 1 2 3 96
The future of the elderly population health status: Filling a knowledge gap 0 0 1 4 5 8 11 22
The increasing value of education to health 0 0 1 23 1 1 5 102
The link between public and private insurance and HIV-related mortality 0 0 0 33 0 3 4 302
The long-term impact of functional disability on hospitalization spending in Singapore 0 0 0 4 3 7 12 43
The potential impact of comparative effectiveness research on U.S. Health Care expenditures 0 0 0 0 2 4 5 27
The reallocation of compensation in response to health insurance premium increases 0 0 0 13 2 5 6 170
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 15 1 3 4 100
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 26 1 2 3 103
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 21 2 3 4 127
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 1 0 0 2 17
Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000 0 0 0 8 1 3 4 84
Total Journal Articles 3 8 24 1,981 105 218 403 11,527
1 registered items for which data could not be found

Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Economic Dimensions of Personalized and Precision Medicine 0 0 0 0 2 4 5 60
Frontiers in Health Policy Research, Volume 10 0 0 0 0 1 5 7 48
Frontiers in Health Policy Research, volume 12 0 0 0 0 2 3 5 72
Frontiers in Health Policy Research, volume 13 0 0 0 0 2 2 3 62
Total Books 0 0 0 0 7 14 20 242

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis 0 0 0 24 1 1 4 84
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 0 0 1 2 31
Disability Forecasts and Future Medicare Costs 0 0 0 23 2 3 6 111
Disability and Spending Growth 0 0 0 5 1 1 2 30
Food Prices and the Dynamics of Body Weight 0 0 0 14 3 6 6 78
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 0 2 6 104 1 7 21 266
Introduction to "Economic Dimensions of Personalized and Precision Medicine" 0 0 0 23 1 4 5 93
Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 4 0 1 2 33
The Effects of Product Liability Exemption in the Presence of the FDA 0 0 0 24 1 1 4 132
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 0 1 1 2 41
Total Chapters 0 2 6 221 11 26 54 899

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2026-01-09